Cineplex (TSE:CGX – Get Free Report) had its price target upped by equities research analysts at BMO Capital Markets from C$13.00 to C$14.00 in a note issued to investors on Friday,BayStreet.CA reports. BMO Capital Markets’ price target would indicate a potential upside of 18.04% from the company’s current price.
Several other equities research analysts also recently commented on CGX. Scotiabank upped their price objective on shares of Cineplex from C$12.00 to C$12.75 and gave the company an “outperform” rating in a report on Wednesday, August 13th. National Bankshares dropped their price objective on shares of Cineplex from C$13.50 to C$13.00 and set an “outperform” rating on the stock in a report on Tuesday, September 30th. Finally, Canaccord Genuity Group upped their price objective on shares of Cineplex from C$11.00 to C$13.00 in a report on Friday. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of C$13.35.
Cineplex Price Performance
About Cineplex
Cineplex is a diversified media company that operates chains of movie theaters. The company has four reporting segments: film entertainment and content; media; amusement and leisure; and location-based entertainment. The film entertainment and content segment includes revenue from theater attendance.
Further Reading
- Five stocks we like better than Cineplex
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Johnson & Johnson’s M&A Strategy Is the Real Story for Investors
- Are Penny Stocks a Good Fit for Your Portfolio?
- Tesla: Some Analysts Are Calling for A 30% Drop—Time to Panic?
- Ride Out The Recession With These Dividend Kings
- Hedge Funds Flip on the Dollar—A Buy Signal for These 3 Stocks?
Receive News & Ratings for Cineplex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cineplex and related companies with MarketBeat.com's FREE daily email newsletter.